Updated: Dec 7, 2019
Mark Avery didn't end his lifelong dream of playing major league baseball--his body did. Within just three years of graduating college, Avery's body had already endured more than a dozen surgeries, more than a dozen concussions, and countless injuries before he was forced off the playing field and into the dugout as a coach.
Avery was a rising star on the baseball diamond at Wayne State University (1989-1992) in Detroit, Michigan where he excelled as a hitter and catcher.
Avery was just as good in the classroom earning Academic All-American honors in 1992 before completing his degree in Mechanical Engineering.
In 1993, Avery signed with the Detroit Tigers to launch his professional baseball career. His minor league career spanned three years, leading to his signing with the Whitesox, ultimately closing due to injury.
In the winter of 1992, while playing before his professional spring training began, Mark launched Avery’s All-star Baseball Camp. It was the first pre-season camp created in the Midwest and the only camp in the country to include catcher specific training. This helped parlay his career into coaching at the collegiate level.
In 1999, Avery took over as Oakland University’s Head Coach where he stayed until 2006. During this time at OU his program produced 12 professional players. Since then Mark has helped over 25 athletes achieve their goals playing professionally. He has also helped over 275 young players receive more than 7 million in college scholarships. He also developed a player symposium that he offers his athletes and their parents. This is designed to help guide them through the process in preparing them for playing at the collegiate and professional levels.
Mark’s Mechanical Engineering degree has only helped in his physics based approach to training players properly. Preventing unnecessary injuries is important to him after being injured himself. This was the catalyst for wanting to train players at a high level without hurting them.
“It happened to me, therefore, I don’t want it to happen to others.”
Currently, local surgeons send Mark players for skilled training with proper form, knowing injury will be avoided.
“After working with me, my player’s arms don’t hurt and it feels good knowing I am making a difference.”
by Mark Avery
September 15, 2018
Pre-treatment physical/mental condition:
Weekly trips to the chiropractor for pain relief. Advil used daily. Multiple concussions (+12), memory loss (short term and long term), Since 1996, can't remember a 7 digit phone number without writing it down. Short-term and long-term tasks require multiple reminders set at 1 hour, 30 minutes and 10 minutes.
I didn't know how much pain I was in until subsided after using ImunStem and Aktiffvate. It's been 23 years since I can remember feeling like close to this. My weekly chiropractor visit is now reduced to once per month and I have not had an advil since using ImunStem and Aktiffvate. My body composition is changing rapidly and my strength is up by over 20% in the first 60 days.
Short term memory is my biggest improvement. In the first 45 days, I remembered events from my childhood and I am sleeping very sound. For the first time in over 20 years, I'm having dreams during sleep.
HEALTH UPDATE Tuesday, June 12, 2019
"I just played in my yearly golf outing and I played 18 holes on Thursday and Friday, and 36 holes on Saturday and I did not need to go to the Chiropractor. I was tired from playing but not that sore. I recovered quickly and I did 10 hours of lesson on Sunday and Monday.
Best Line of the Weekend...
“Avery, where are your jugs of Advil?” I replied, I do not need to take it anymore!”
Thank you for everything!
More to come..
- HEALTH ALERT -
NEW groundbreaking therapies reveal major shift in pharma technology. Regenerative medicine technology may conflict with your past beliefs and education.
The goal is not to undermine your beliefs, nor to undermine the volumes of research from the past 100 years of pharma or the pathogenesis in human beings.
Instead, the goal over the next two-(2) minutes is to raise awareness directly to key stakeholders, insurers/payors, health care providers, and to patients with Serious and Life-threatening conditions.
What are Regenerative Medicines?
As described in the 21st Century Cures Act, a regenerative medicine is:
A. a therapy intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition; and
B. preliminary clinical evidence indicates that the medicine has the potential to address unmet medical needs for such disease or condition.
Physicians report that the Metabolic Plan of Care produces a significant response in 99% of their patients. A reduction of symptoms in patient’s with conditions such as Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Autoimmune Disorders, Cancer, Constipation, Debilitating Chronic Pain, Diabetes, Epilepsy, Fibromyalgia, Fragile-X Syndrome, Hemostasis (less blood to be lost), Hypertention, Menopause, Multiple Sclerosis (MS), Obesity, Osteopenia, Parkinson’s Disease, Prostate, Schizophrenia, Stroke, Thalassemia, Viral Illesses and more.
FOR PUBLIC RELEASE July 1, 2018 -- FDA-Approves ImunStem for serious and life-threatening conditions.
ImunStem® Nat'l Drug Code No.: 70642-001-01 Full Prescribing Information Label
Although ImunStem was reviewed and approved the FDA's prescription drug approval process, ImunStem is truly not a "DRUG", but instead, ImunStem is a "dietary supplement" comprised of Olive leaf extract, Yarrow flowers extract, Rosemary leaf extract, Yucca plant extract and Cassia oil.
ImunStem stimulates the immune system throughout the body.
ImunStem aids in the cellular regeneration of damaged areas of the body through diseases and injuries.
ImunStem helps blood flow through the system especially in difficult regions such as body capillaries.
ImunStem is a highly mobile compound that has been shown as a central nervous system and immune system stimulant.
ImunStem has shown to enhance Deoxyribonucleic Acid (DNA) repair before, during, and after chemotherapy drugs, toxic exposure, and chemical-induced damage.
ImunStem has demonstrated an increase in energy in terminally ill and bedridden patients and for individuals that suffer from a fatigued state.
ImunStem can help improve the immune system by assisting in replenishing depleted White Blood Cells (WBC) which help fight infection.
ImunStem has shown to provide an overall feeling of calmness, well being and an improved quality of sleep.
ImunStem has shown to help reduce loss of blood from surgical wound and menstrual periods (shorter and lighter periods).
ImunStem has shown to provide significant decrease of side-effects to chemotherapy for cancer patients.
ImunStem can act alone safely or with other medical therapies to maximize efficacy and produce faster and lasting benefits to treat serious and life-threatening diseases or conditions by supporting immune system function.
Mechanism of Action
ImunStem is an herbal (botanical) product, which has pathogenesis and homeostatic properties.
The variety of components provides antioxidant activity and a powerful positive effect on the immune system.
ImunStem allows the active ingredients to disperse throughout the body and blood stream; it also has a direct effect upon immune-cell and cellular functioning.
ImunStem has shown to enhance Deoxyribonucleic Acid (DNA) repair before, during, and after chemotherapy drugs, toxic exposure, and chemical-induce damage.
ImunStem modulates anxiety, initially including and then reversing these effects after long-term administration.
ImunStem can play an integral role in hypothalamic activity, easing both parasympathetic and sympathetic nervous systems towards a state of homeostasis.
Since blood pressure level is directly linked to the sympathetic nervous system, the lower blood pressure levels exhibited following administration of ImunStem is compatible with the stabilization of sympathetic nervous system activity.
The pulmonary benefits observed are likely due to the focus of deep breathing, this places less pressure on lungs and increases lung capacity, as well as overall improvement seen in breathing efficiency.
ImunStem is readily absorbed into soft tissue matter when taken as an oral dose. This is accomplished because ImunStem readily passes through membrane tissue by passive diffusion penetrating to the circulatory system.
ImunStem is a fast acting substance. Once the onset of action takes place patients can notice calmness, improved breathing, mental clarity, and alertness immediately.
It is postulated that in arresting abnormal cellular mutation, the precursors for normal and enhanced cellular regeneration and cellular division can be accelerated in relation to the selective existing disease pathology.
Observations of in-vivo testing that display the ability for ImunStem components to dissolve in hydrophilic substances propose that in the finished chemical form of the product and with its unique makeup, ImunStem produces a bipolarity that facilitates molecular diffusion through various permeable and selective membranes. It is therefore theorized that the combination of the bodies’ thermal energy particularly during variance mutation and inflammatory processes, potentiates the self-propelling of molecules by possible passive membrane transportation or passive diffusion of the ImunStem compound intact to cross the blood brain barrier also displaying lipophilicity (or lipophilic quality) to retain efficacy and activity for the central nervous system.
In-vivo studies involving treated test subjects have immune system activity in tests including blood tests and have provided the efficacious ability to improve immune system function while maintaining the cellular structure to tissue intact. These studies also reveal that ImunStem continues to provide improved immune system function with long term use.
- WORLD CLASS PROVIDERS -
Dr. Stephen R. Meis, M.D. is a California Board Certified Physician with thirty-(30) years service in the field of Primary Care and Family Practice. Dr. Meis is Medical Director at Golden Sunrise Nutraceutical, Inc. focused on research, development, and training for new doctors entering utilizing regenerative therapies for the treatment of Serious and Life-threatening conditions, terminal illnesses, cancers, and other incurable diseases. Dr. Meis recieved his Medical Education at Creighton University School of Medicine in Omaha, Nebraska; Residency - Family Practice, California Medical Center Los Angeles. Certifications - American Board of Family Medicine.
Dr. Mumtaz M. George, M.D. has been passionate about curing patients for more than forty (40) years in internal medicine. Dr George is located near Detroit, MI with offices in Royal Oak, MI. Birmingham Royal Oak Medical Group has an on-site laboratory, which minimizes waiting for answers. Innovative technology makes it possible for the team to expedite MRIs, testing, blood panels, X-rays, Comprehensive Cholesterol Testing, Drug Testing, Echocardiogram, EKG, Lab, Digital X-ray, Pulmonary Function Test, and STD Testing. Dr. George graduated from Universidad De Granada, Facultad De Medicina and specializes in internal medicine and emergency medicine.
- CANCER -
More than 1.75 million people are diagnosed with cancer annually making it the second leading cause of death. The cost of cancer care is rising and expected to reach $174 billion by 2020. 2019 Cancer Survival Rate Results
HEART DISEASE | STROKE
More than 859,000 Americans die of heart disease or stroke annually—that’s one-third of all deaths costing our health care system $199 billion per year and causing $131 billion in lost productivity.
More than 30 million Americans have diabetes, and another 84 million adults in the United States have prediabetes. Diabetes can cause heart disease, kidney failure, and blindness, and costs the US health care system and employers $237 billion annually.
Affects 1 in 5 children and 1 in 3 adults, putting people at risk for diabetes, heart disease, and cancer. Obesity costs the US health care system $147 billion a year.
Affects 54.4 million adults in the U.S. which is about 1 in 4 adults. The cost is nearly $140 billion medical costs and $164 billion for indirect costs associated with lost earnings.
ALZHEIMER'S / DEMENTIA
A type of dementia, affects about 5.7 million Americans and is the sixth leading cause of death. Costs are projected to jump to between $379 billion and $500 billion annually.
Affects more than 3 million adults and 470,000 children and teens younger than 18. Costs for a person with epilepsy range from $10,200 to $47,900 per year.
- Donate Life-saving Treatments -
This year, more than one-(1) million Americans will die from failed treatments for cancer or other terminal illness.
Despite the overwhelming need, some physicians will not prescribe regenerative therapies-- forcing the patient to pay for the cost as an out-of-pocket expense instead of being covered by insurance.
As a result of this, many who would benefit from these groundbreaking regenerative medicines are unable to purchase them.
Altruistic United Humanity Association (AUHA), a 501(c)(3) charitable organization based in Porterville, CA, was asked to help in making Golden Sunrise products more readily available to the public--with the donations helping to lower the total cost to the patient. A portion of the donated monies are also used to further Golden Sunrise's research to develop herbal treatments for other life-threatening diseases and conditions. [Learn More]
"Healthy Body & Mind Screening"
Upcoming Events [click here]
Dana Lihan - email@example.com - (954) 639-4584
Bonnie McCollough - firstname.lastname@example.org - (504) 228-2571
- EXPECT MIRACLES -
"My personal miracle of curing cancer is now a national campaign to raise awareness for life-saving therapies. If your health needs attention, treatments are available that could change your--or the life of someone you love. It did mine." ~ Rusty Hilger
MERGERS & AQUISITIONS For more than a decade, the world's largest drugmakers have watched as Golden Sunrise Pharmaceutical (GSP) and herbalist Huu Tieu successfully completed of each phase of the FDA Drug Approval Process. GSP became the target of multiple attempts for control.
REVOLUTIONARY TECHNOLOGY Drugmakers have learned that reverse engineering is NOT possible. Isolating the active ingredient is not possible. There will be NO GENERIC.
Golden Sunrise Nutraceutical, Inc. and Golden Sunrise Pharmaceutical, Inc., are privately-held U.S. corporations; - Mr. Huu Tieu (CEO) and Mr. Martin Loeffler (VP);
ASSETS: - Mr. Huu Tieu (CEO)
- Mr. Martin Loeffler (VP)
- FDA-approval; - patented technology;
- no debt; - multiple SKU's; - currently manufacturing (multiple SKU's) . - no competition; - no generic option will be available;
The following SKU's are High Demand:
ImunStem One-pallet contains 3,240 units - 30ml (1 ounce) Glass bottles w/dropper) - Carton: 15 bottles per carton. Retail Price to Patient: $500 per unit.
Aktiffvate One-pallet contains 3,240 units - 30ml (1 ounce) Glass bottles w/dropper) - Carton: 15 bottles per carton. Retail Price to Patient: $500 per unit.
KemoHerb (See Cancer Plan of Care) Retail to Patient: $3,000 per treatment.
DetoxHerb (See Metabolic Plan of Care) Retail to Patient: $2,000 per treatment.
Corporate Plan- positioning for initial public offering (IPO);
- current valuation: eight billion ($8,000,000,000) USD